Phosphoproteomics Identifies PI3K Inhibitor–selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phosphoproteomics Identifies PI3K Inhibitor–selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistance

Published:2021-09-22 Issue:12 Volume:20 Page:2433-2445
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Cintas Célia^ORCID,Douche Thibault^ORCID,Dantes Zahra^ORCID,Mouton-Barbosa Emmanuelle,Bousquet Marie-Pierre^ORCID,Cayron Coralie^ORCID,Therville Nicole^ORCID,Pont Frédéric,Ramos-Delgado Fernanda,Guyon Camille^ORCID,Garmy-Susini Barbara,Cappello Paola^ORCID,Burlet-Schiltz Odile,Hirsch Emilio^ORCID,Gomez-Brouchet Anne,Thibault Benoît,Reichert Maximilian,Guillermet-Guibert Julie

Funder

RITC

Université de Toulouse

Ligue Nationale Contre le Cancer

Fondation pour la recherche Médicale FRM

Fondation FONROGA

Fondation de France

MSCA-ITN-PhD

COST PanGenEU

Université Paul Sabatier for French-German student exchange

German Research Foundation

German Cancer Aid Foundation

Région Midi-Pyrénées, European funds

French Ministry of Research

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting PI3K family with small-molecule inhibitors in cancer therapy: current clinical status and future directions;Molecular Cancer;2024-08-10

2. Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases;Science Advances;2024-03-29

3. Isoform-selective targeting of PI3K: time to consider new opportunities?;Trends in Pharmacological Sciences;2023-09

4. Integrins in cancer: Emerging mechanisms and therapeutic opportunities;Pharmacology & Therapeutics;2023-07

5. Targeting Class I-II-III PI3Ks in Cancer Therapy: Recent Advances in Tumor Biology and Preclinical Research;Cancers;2023-01-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3